Target intelligence / Profile preview

MT-ND4L pseudogene 18 (MTND4LP18)

Target
MTND4LP18
Molecular classification
Other (Pseudogene)
01

Overview

MTND4LP18 (MT-ND4L pseudogene 18) is classified as a pseudogene, specifically a nuclear pseudogene related to the mitochondrial gene MT-ND4L, which encodes a subunit of mitochondrial complex I but does not itself encode a functional protein, participate in mitochondrial respiration, or serve as a drug or therapeutic target[6]. No known biological function, disease association, or drug interaction has been reported for this pseudogene as of current genetic databases[6].

Other names
MTND4LP18MT-ND4L Pseudogene 18

Beyond the preview

Go deeper on MT-ND4L pseudogene 18 (MTND4LP18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND4L pseudogene 18 (MTND4LP18).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call